These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34721388)

  • 1. Can the Cytokine Profile According to ABO Blood Groups Be Related to Worse Outcome in COVID-19 Patients? Yes, They Can.
    Tamayo-Velasco Á; Peñarrubia Ponce MJ; Álvarez FJ; Gonzalo-Benito H; de la Fuente I; Pérez-González S; Rico L; Jiménez García MT; Sánchez Rodríguez A; Hijas Villaizan M; Martín-Fernández M; Dueñas C; Gómez-Sánchez E; Heredia-Rodríguez M; Gorgojo-Galindo Ó; Fernández I; Del Río L; Carnicero-Frutos I; Muñoz-Moreno MF; Tamayo E; Bernardo D; Martínez-Paz P
    Front Immunol; 2021; 12():726283. PubMed ID: 34721388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19.
    Hoiland RL; Fergusson NA; Mitra AR; Griesdale DEG; Devine DV; Stukas S; Cooper J; Thiara S; Foster D; Chen LYC; Lee AYY; Conway EM; Wellington CL; Sekhon MS
    Blood Adv; 2020 Oct; 4(20):4981-4989. PubMed ID: 33057633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
    Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
    Front Immunol; 2021; 12():700921. PubMed ID: 34539631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness : A Population-Based Cohort Study.
    Ray JG; Schull MJ; Vermeulen MJ; Park AL
    Ann Intern Med; 2021 Mar; 174(3):308-315. PubMed ID: 33226859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine Elevation in Severe COVID-19 From Longitudinal Proteomics Analysis: Comparison With Sepsis.
    Ebihara T; Matsumoto H; Matsubara T; Togami Y; Nakao S; Matsuura H; Kojima T; Sugihara F; Okuzaki D; Hirata H; Yamamura H; Ogura H
    Front Immunol; 2021; 12():798338. PubMed ID: 35095877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the ABO blood group and COVID-19 susceptibility, severity and mortality in two cohorts of patients.
    Muñiz-Diaz E; Llopis J; Parra R; Roig I; Ferrer G; Grifols J; Millán A; Ene G; Ramiro L; Maglio L; García N; Pinacho A; Jaramillo A; Peró A; Artaza G; Vallés R; Sauleda S; Puig L; Contreras E
    Blood Transfus; 2021 Jan; 19(1):54-63. PubMed ID: 33196417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer.
    Nagant C; Ponthieux F; Smet J; Dauby N; Doyen V; Besse-Hammer T; De Bels D; Maillart E; Corazza F
    Int J Infect Dis; 2020 Dec; 101():342-345. PubMed ID: 33039609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between ABO blood groups and COVID-19 infection, severity and demise: A systematic review and meta-analysis.
    Wu BB; Gu DZ; Yu JN; Yang J; Shen WQ
    Infect Genet Evol; 2020 Oct; 84():104485. PubMed ID: 32739464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients.
    Perreau M; Suffiotti M; Marques-Vidal P; Wiedemann A; Levy Y; Laouénan C; Ghosn J; Fenwick C; Comte D; Roger T; Regina J; Vollenweider P; Waeber G; Oddo M; Calandra T; Pantaleo G
    Nat Commun; 2021 Aug; 12(1):4888. PubMed ID: 34373466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct cytokine profiles associated with COVID-19 severity and mortality.
    Dorgham K; Quentric P; Gökkaya M; Marot S; Parizot C; Sauce D; Guihot A; Luyt CE; Schmidt M; Mayaux J; Beurton A; Le Guennec L; Demeret S; Ben Salah E; Mathian A; Yssel H; Combadiere B; Combadiere C; Traidl-Hoffmann C; Burrel S; Marcelin AG; Amoura Z; Voiriot G; Neumann AU; Gorochov G
    J Allergy Clin Immunol; 2021 Jun; 147(6):2098-2107. PubMed ID: 33894209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection.
    Horspool AM; Kieffer T; Russ BP; DeJong MA; Wolf MA; Karakiozis JM; Hickey BJ; Fagone P; Tacker DH; Bevere JR; Martinez I; Barbier M; Perrotta PL; Damron FH
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33472985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of ABO blood group to COVID-19 infections: clinico-hematological, radiological, and complications analysis.
    Kabrah SM; Abuzerr SS; Baghdadi MA; Kabrah AM; Flemban AF; Bahwerth FS; Assaggaf HM; Alanazi EA; Alhifany AA; Al-Shareef SA; Alsabban WH; Khan AA; Alzhrani H; Jambi LK; Alsafi RT; Aslam A; Kabrah HM; Babalghith AO; Halawani AJ
    Medicine (Baltimore); 2021 Dec; 100(52):e28334. PubMed ID: 34967364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of blood group types on the risk of COVID-19 infection and its clinical outcome.
    Göker H; Aladağ Karakulak E; Demiroğlu H; Ayaz Ceylan ÇM; Büyükaşik Y; Inkaya AÇ; Aksu S; Sayinalp N; Haznedaroğlu IC; Uzun Ö; Akova M; Özcebe OI; Ünal S
    Turk J Med Sci; 2020 Jun; 50(4):679-683. PubMed ID: 32496734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between ABO blood types and the prognosis and mortality rates in patients with severe COVID-19 admitted in the intensive care unit of a tertiary-level hospital in Turkey.
    Koç S; Karcioglu Batur L
    Curr Med Res Opin; 2022 Sep; 38(9):1515-1520. PubMed ID: 35848063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19.
    Azmy V; Kaman K; Tang D; Zhao H; Dela Cruz C; Topal JE; Malinis M; Price CC
    J Clin Immunol; 2021 May; 41(4):738-747. PubMed ID: 33459964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients.
    Luft T; Wendtner CM; Kosely F; Radujkovic A; Benner A; Korell F; Kihm L; Bauer MF; Dreger P; Merle U
    Front Immunol; 2021; 12():634416. PubMed ID: 34248931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-γ is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection.
    Gadotti AC; de Castro Deus M; Telles JP; Wind R; Goes M; Garcia Charello Ossoski R; de Padua AM; de Noronha L; Moreno-Amaral A; Baena CP; Tuon FF
    Virus Res; 2020 Nov; 289():198171. PubMed ID: 32979474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lewis and ABO histo-blood types and the secretor status of patients hospitalized with COVID-19 implicate a role for ABO antibodies in susceptibility to infection with SARS-CoV-2.
    Matzhold EM; Berghold A; Bemelmans MKB; Banfi C; Stelzl E; Kessler HH; Steinmetz I; Krause R; Wurzer H; Schlenke P; Wagner T
    Transfusion; 2021 Sep; 61(9):2736-2745. PubMed ID: 34151460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome.
    Blot M; Bour JB; Quenot JP; Bourredjem A; Nguyen M; Guy J; Monier S; Georges M; Large A; Dargent A; Guilhem A; Mouries-Martin S; Barben J; Bouhemad B; Charles PE; Chavanet P; Binquet C; Piroth L;
    J Transl Med; 2020 Dec; 18(1):457. PubMed ID: 33272291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood type and outcomes in patients with COVID-19.
    Latz CA; DeCarlo C; Boitano L; Png CYM; Patell R; Conrad MF; Eagleton M; Dua A
    Ann Hematol; 2020 Sep; 99(9):2113-2118. PubMed ID: 32656591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.